3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
27
Carcinoma, Hepatocellular
26
Small Cell Lung Carcinoma
17
Lung Neoplasms
15
Neoplasms
13
Breast Neoplasms
8
Colorectal Neoplasms
7
Carcinoma, Renal Cell
7
Squamous Cell Carcinoma of Head and Neck
6
Melanoma
6
Uterine Cervical Neoplasms
5
Urinary Bladder Neoplasms
5
Triple Negative Breast Neoplasms
5
Neoplasm Metastasis
5
Carcinoma, Transitional Cell
5
Prostatic Neoplasms
4
Glioblastoma
4
Stomach Neoplasms
3
Solid Tumors
3
Sarcoma, Alveolar Soft Part
3
Sarcoma
3
Liver Neoplasms
3
Extensive Stage Lung Small Cell Carcinoma
3
Carcinoma
3
Treatment-Refractory Solid Tumors
2
Small Cell Lung Cancer Extensive Stage
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Osteosarcoma
2
Nasopharyngeal Carcinoma
2
Interventions
talimogene laherparepvec
1
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
Vorinostat
1
Taxes
1
Radiotherapy, Conformal
1
Paclitaxel
1
Mastectomy, Segmental
1
Mastectomy
1
Carboplatin
1
Brachytherapy
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Ductal, Breast
×
atezolizumab
×
90 days
×
Clear all
No trials found.